What You Should Know:
- Eko Health, a pioneer in applying artificial intelligence for early detection of heart and lung diseases, today announced the issuance of a Category III Current Procedural Terminology (CPT) code by the American Medical Association (AMA) for its SENSORA™ platform.
-The newly issued Category III CPT code will be effective on July 1, 2025, and is the first step to coverage and reimbursement for SENSORA™, bringing advanced heart disease detection to clinicians across
Read More
Eko Devices
LSU Becomes First College Sports Program to Use Eko AI-Powered Stethoscopes
What You Should Know:
- Eko Health, a leader in AI-powered cardiac care, has joined forces with LSU Athletics and Our Lady of the Lake Health to revolutionize heart health care for student-athletes.
- Through this groundbreaking partnership, LSU Athletics becomes the first college sports program to utilize Eko Health’s FDA-cleared CORE 500 digital stethoscopes and AI algorithms for early detection of heart conditions.
AI-Powered Stethoscopes to Enhance LSU Athletics
Read More
Eko Health Raises $41M to Scale AI-driven Heart, Lung Detection
What You Should Know:
- Eko Health, a leader in AI-powered early detection of heart and lung diseases, announced today a successful Series D financing round of $41 million.
- This funding, led by ARTIS Ventures, Highland Capital Partners, NTTVC, and Questa Capital, will fuel Eko's mission to expand access to its innovative platform in the U.S. and globally.
Building on a Strong Foundation of Innovation and Clinical Validation
This funding round comes on the heels of
Read More
15-Second Heart Failure Test: Eko’s AI Stethoscope Gets FDA Nod
What You Should Know:
- Eko Health, a provider of AI-powered heart and lung disease detection today announced FDA clearance for its Low EF detection AI.
- Built in collaboration with Mayo Clinic, the AI allows U.S. healthcare providers to detect Low Ejection Fraction (LVEF), a crucial indicator of heart failure, in just 15 seconds using a standard Eko stethoscope during a routine physical exam.
Importance of Early Detection
The advancement in early detection signifies a major medical
Read More
FIGS & Eko Health Launches New Digital Stethoscope
What You Should Know:
FIGS, Inc. (NYSE: FIGS), the direct-to-consumer healthcare apparel and lifestyle brand, and Eko Health, Inc. (“Eko”), a leading innovator in digital health technology for heart and lung disease detection, today announced the launch of the FIGS | Eko CORE 500TM Digital Stethoscope.The collaboration unites two companies that have reinvented two healthcare professionals’ mainstays — scrubs and stethoscopes — through new technology, modern design, and authentic
Read More
Eko Health Launches AI-Enhanced Digital Stethoscope
What You Should Know:
Eko Health today announced the launch of its next-generation AI-enhanced digital stethoscope, CORE 500™. Engineered to enhance diagnostic accuracy and early disease detection, the CORE 500™ combines artificial intelligence (AI) software, high-fidelity audio experience, full-color display, and 3-lead electrocardiogram (ECG) to deliver an essential patient assessment tool for healthcare professionals (HCPs).
CORE 500 Features
The CORE
Read More
Eko Launches Cardiac Disease Detection Platform, SENSORA
What You Should Know:
- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart and lung disease launches the SENSORA™ Cardiac Disease Detection Platform.
- SENSORA™ currently features AI that objectively identifies structural murmurs, a sign of valvular heart disease, and Care Pathway Analytics software that provides downstream visibility and metrics of the patient journey through the healthcare system.
Eko SENSORA Cardiac Disease Detection
Read More
FDA Clears Eko’s Heart Disease Detection AI for Adults and Pediatrics
What You Should Know:
- Today, Eko, a digital health company advancing heart and lung disease detection, has announced the FDA has issued clearance for its Eko Murmur Analysis Software (EMAS), the first and only machine learning algorithm to screen for valvular heart disease (VHD).
- The next generation of Eko’s murmur detection capabilities grants Eko the first and only smart stethoscope on the market that can identify and
Read More
Eko Unveils Newly Designed Heart Disease Detection App
What You Should Know:
- Eko, a digital health company advancing heart and lung disease detection, today announced the launch of its newly-redesigned Eko App, which will transform patient interactions into an opportunity to screen for cardiovascular disease. Heart disease is the leading cause of death in the U.S., and there has not been an efficient and affordable solution to screen for heart disease at the physical exam until now.
- Eko has transformed the traditional stethoscope into an
Read More
Eko Launches Next Generation DUO ECG + Digital Stethoscope for Frontline Clinicians
What You Should Know:
- Eko, a cardiopulmonary digital health company launches its next-generation Eko DUO, an FDA-cleared cardiac assessment tool that functions as an electrocardiogram (ECG) and digital stethoscope to detect early signs of heart disease and facilitate timely care and personalized disease management.
- DUO is a pocket-sized cardiac examination system for clinicians used to detect early signs of heart disease and facilitate timely care for patients in and out of the clinic.
Read More
